PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,843,000 | -53.2% | 443,917 | -39.9% | 0.01% | -54.5% |
| Q3 2016 | $10,354,000 | +98.6% | 739,043 | -0.5% | 0.01% | +120.0% |
| Q2 2016 | $5,214,000 | +10.7% | 742,711 | +1.5% | 0.01% | 0.0% |
| Q1 2016 | $4,711,000 | -71.3% | 731,433 | +44.6% | 0.01% | -70.6% |
| Q4 2015 | $16,393,000 | +24.2% | 505,966 | +2.3% | 0.02% | +21.4% |
| Q3 2015 | $13,201,000 | -40.0% | 494,398 | +8.2% | 0.01% | -39.1% |
| Q2 2015 | $21,986,000 | -3.0% | 456,801 | +22.6% | 0.02% | 0.0% |
| Q1 2015 | $22,671,000 | +46.1% | 372,564 | +24.3% | 0.02% | +43.8% |
| Q4 2014 | $15,520,000 | +3016.5% | 299,800 | +2549.6% | 0.02% | – |
| Q3 2014 | $498,000 | -54.4% | 11,315 | -72.9% | 0.00% | -100.0% |
| Q2 2014 | $1,093,000 | -48.7% | 41,813 | -48.7% | 0.00% | -50.0% |
| Q1 2014 | $2,129,000 | -20.0% | 81,429 | -48.1% | 0.00% | -33.3% |
| Q4 2013 | $2,661,000 | -20.6% | 156,800 | +0.4% | 0.00% | 0.0% |
| Q3 2013 | $3,350,000 | – | 156,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |